KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Ionis Pharmaceuticals (IONS) over the last 17 years, with Q3 2025 value amounting to $41.1 million.

  • Ionis Pharmaceuticals' Net Cash Flow rose 212.86% to $41.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year increase of 11931.88%. This contributed to the annual value of -$156.9 million for FY2024, which is 22815.54% down from last year.
  • Ionis Pharmaceuticals' Net Cash Flow amounted to $41.1 million in Q3 2025, which was up 212.86% from $32.5 million recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Net Cash Flow ranged from a high of $236.3 million in Q4 2021 and a low of -$326.5 million during Q1 2022
  • For the 5-year period, Ionis Pharmaceuticals' Net Cash Flow averaged around -$3.1 million, with its median value being $21.9 million (2025).
  • Its Net Cash Flow has fluctuated over the past 5 years, first tumbled by 206499.97% in 2022, then skyrocketed by 67314.34% in 2023.
  • Over the past 5 years, Ionis Pharmaceuticals' Net Cash Flow (Quarter) stood at $236.3 million in 2021, then tumbled by 116.53% to -$39.1 million in 2022, then skyrocketed by 219.99% to $46.9 million in 2023, then crashed by 296.35% to -$92.0 million in 2024, then soared by 144.67% to $41.1 million in 2025.
  • Its Net Cash Flow stands at $41.1 million for Q3 2025, versus $32.5 million for Q2 2025 and $21.9 million for Q1 2025.